Hologic

Historical price data

Hologic is a mission-driven leader in women's healthcare technology, founded in 1985 and publicly traded on NASDAQ. The company has achieved market leadership through its gold-standard 3D mammography systems and high-throughput molecular diagnostics platforms, establishing a comprehensive continuum of care. Its strategy focuses on innovation within its core platforms, global expansion, and strategic acquisitions, recently underscored by a definitive agreement to be acquired by private equity firms Blackstone and TPG for up to $79 per share, signaling strong confidence in its future growth and stability.

Hologic's integrated platform combines gold-standard 3D breast imaging (tomosynthesis), fully automated high-throughput molecular diagnostics (Panther® system with Aptima® assays), and minimally invasive gynecological surgical solutions to address the full continuum of women's healthcare.

Hologic competes with large, well-capitalized players: in Breast Imaging vs. GE HealthCare and Siemens; in Diagnostics vs. Roche, Abbott, and Danaher. Its differentiated, integrated focus on women's health provides a unique ecosystem advantage, but it must continuously innovate to maintain leadership against these formidable competitors.